News | Cardiac Diagnostics | July 01, 2016

Anabolic Steroid Abuse May Increase Arrhythmia, Stroke Risk

Study shows that people with the inherited heart condition ARVC could be at particular risk

anabolic steroid abuse, ARVC, arrhythmia, stroke, British Cardiovascular Society conference

July 1, 2016 — Research has already shown that taking anabolic steroids is associated with high blood pressure and an increased risk of developing heart conditions such as left ventricular hypertrophy.

Now research, part-funded by the British Heart Foundation and presented at this year’s British Cardiovascular Society conference, June 6-8 in Manchester, England, has shown that for some people misusing steroids can be particularly dangerous.

A team of researchers from the University of Birmingham (U.K.) have found evidence to suggest that, when taken by people with the inherited heart condition arrhythmogenic right ventricular cardiomyopathy (ARVC), steroids could lead to changes in heart muscle structure and problems with the heart’s electrical signals. These changes would then increase the likelihood that people taking steroids would suffer from atrial fibrillation, an abnormal heart rhythm disorder which is itself a major cause of stroke.

ARVC is caused by a mutation in one or more genes responsible for producing the proteins that hold the heart muscle together. The researchers gave dihydrotestosterone, an anabolic steroid commonly used to enhance athletic performance, to mice with a deficiency in one of these same proteins.

They found that, in these hearts, the electrical signal that tells the heart when to beat travelled around the heart more slowly than usual. This slowing down of electrical activity put these hearts at greater risk of dangerous abnormal heart rhythms, such as atrial fibrillation.

It is estimated that hundreds of thousands of people in the United Kingdom have used anabolic steroids for non-medical purposes in their lifetime. Anabolic steroids are prescription-only medicines that are sometimes taken without medical advice to increase muscle mass and improve athletic performance. If used in this way, they can cause serious side effects and addiction.

Larissa Fabritz, senior author and reader in cardiovascular sciences at the University of Birmingham, said, “With one in every five men joining a gym in the U.K. using performance-enhancing anabolic steroids the misuse of steroids is fast becoming an emerging global health problem. Our results show that the misuse of steroids could explain why seemingly healthy individuals are suffering from serious heart problems.”

Jeremy Pearson, associate medical director at the British Heart Foundation, said, “This study reinforces the evidence that using anabolic steroids can have untoward and possibly dangerous side effects, particularly in those who, often unknowingly, have heart problems.”

For more information: www.bcs.com/conference

Related Content

U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack, according to research...
HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy
News | Cardiac Diagnostics | May 14, 2019
The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and...
New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
PTSD Alone Does Not Increase Heart Disease Risk in Veterans
News | Cardiac Diagnostics | February 20, 2019
February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the...
Hormone Therapy May Increase Cardiovascular Risk During Gender Transition
News | Cardiac Diagnostics | February 18, 2019
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular...
Overlay Init